192 related articles for article (PubMed ID: 31191822)
1. Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas.
Loewenstern J; Rutland J; Gill C; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride R; Donovan M; Sebra R; Bederson J; Fowkes M; Shrivastava R
Oncotarget; 2019 May; 10(37):3506-3517. PubMed ID: 31191822
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
[TBL] [Abstract][Full Text] [Related]
3. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
4. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
7. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genomic factors associated with seizures in meningiomas.
Gupte TP; Li C; Jin L; Yalcin K; Youngblood MW; Miyagishima DF; Mishra-Gorur K; Zhao AY; Antonios J; Huttner A; McGuone D; Blondin NA; Contessa JN; Zhang Y; Fulbright RK; Gunel M; Erson-Omay Z; Moliterno J
J Neurosurg; 2020 Dec; 135(3):835-844. PubMed ID: 33276341
[TBL] [Abstract][Full Text] [Related]
9. SWI/SNF chromatin remodeling complex alterations in meningioma.
Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas.
Tian W; Liu J; Zhao K; Wang J; Jiang W; Shu K; Lei T
Front Oncol; 2020; 10():593073. PubMed ID: 33425743
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
13. ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.
Chaluts D; Dullea JT; Ali M; Vasan V; Devarajan A; Rutland JW; Gill CM; Ellis E; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5165-5172. PubMed ID: 36348021
[TBL] [Abstract][Full Text] [Related]
14. Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma.
Mathew Thomas V; Bindal P; Vredenburgh JJ
Case Rep Oncol; 2019; 12(1):126-130. PubMed ID: 31043950
[TBL] [Abstract][Full Text] [Related]
15. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.
Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR
Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312
[TBL] [Abstract][Full Text] [Related]
16. Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
González-Tablas M; Prieto C; Arandia D; Jara-Acevedo M; Otero Á; Pascual D; Ruíz L; Álvarez-Twose I; García-Montero AC; Orfao A; Tabernero MD
Front Oncol; 2021; 11():740782. PubMed ID: 34868937
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas.
Kuranari Y; Tamura R; Tsuda N; Kosugi K; Morimoto Y; Yoshida K; Toda M
Front Oncol; 2020; 10():592470. PubMed ID: 33330078
[TBL] [Abstract][Full Text] [Related]
18.
Dullea JT; Chaluts D; Vasan V; Rutland JW; Gill CM; Ellis E; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
Br J Neurosurg; 2023 Apr; ():1-7. PubMed ID: 37096420
[TBL] [Abstract][Full Text] [Related]
19. WHO grade II and III meningiomas: a study of prognostic factors.
Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
[TBL] [Abstract][Full Text] [Related]
20. Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
Ren L; Xie Q; Deng J; Chen J; Yu J; Wang D; Wakimoto H; Gong Y; Hua L
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38552238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
